Neonatal Meningitis: A Prospective Observational Study On Microbial Etiology, Cerebrospinal Fluid Pathology, And Clinical Outcomes
DOI:
https://doi.org/10.52783/jns.v14.2096Keywords:
Neonatal meningitis, cerebrospinal fluid analysis, bacterial pathogens, antibiotic resistance, neonatal outcomes, central IndiaAbstract
Background: Neonatal meningitis is a severe and potentially fatal condition that continues to pose a significant challenge in developing countries. Understanding the microbial etiology, cerebrospinal fluid (CSF) characteristics, and clinical outcomes is essential for optimizing treatment strategies and improving neonatal survival rates.
Methods: This prospective observational study was conducted in multiple tertiary care centers across central India over one year. Neonates presenting with clinical signs suggestive of meningitis underwent lumbar puncture for CSF analysis. Microbiological testing, including Gram staining, culture, and PCR analysis, was performed to identify the causative pathogens. CSF parameters such as protein, glucose, and cell counts were documented. Clinical outcomes were evaluated based on recovery, neurological sequelae, and mortality rates.
Results: Escherichia coli was identified as the predominant pathogen, followed by Klebsiella pneumoniae. Significant antibiotic resistance patterns were observed, particularly resistance to Ampicillin and Cefotaxime. Elevated CSF protein levels and reduced glucose concentrations were commonly observed in bacterial meningitis cases. Neonates treated with Ceftriaxone and Amikacin demonstrated the highest recovery rates, whereas those requiring Colistin and Tigecycline had poorer outcomes. The study highlighted a higher risk of prolonged hospitalization and complications in severe cases.
Conclusion: This study underscores the critical need for improved diagnostic strategies, targeted antibiotic regimens, and enhanced neonatal care practices. Strengthening maternal screening programs and adopting emerging diagnostic technologies may significantly improve outcomes in neonatal meningitis cases.
Downloads
Metrics
References
Bedford, H., & de Louvois, J. (1995). Bacterial meningitis in neonates: A prospective study of mortality and morbidity. Archives of Disease in Childhood. Fetal and Neonatal Edition, 72(2), F111-F115.
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010). Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical Microbiology Reviews, 23(3), 467-492.
Edmond, K., & Zaidi, A. (2010). New approaches to preventing, diagnosing, and treating neonatal sepsis. PLoS Medicine, 7(3), e1000213.
Kim, K. S. (2010). Pathogenesis of bacterial meningitis: From bacteraemia to neuronal injury. Nature Reviews Neuroscience, 11(8), 585-595.
Ku, L. C., & Boggess, K. A. (2015). Bacterial meningitis in the neonate: Clinical features and diagnosis. Neonatal Infectious Diseases Journal, 34(2), 120-128.
Li, Y., Yin, L., Chen, S., Chen, X., & Shao, Z. (2014). Multidrug-resistant Klebsiella pneumoniae infections in neonates: A retrospective analysis. The Pediatric Infectious Disease Journal, 33(9), e233-e238.
Malik, A. S., & Pennie, R. A. (1994). The epidemiology of bacterial meningitis in children. Journal of Infection, 28(1), 79-85.
Nizet, V., & Klein, J. O. (2004). Bacterial sepsis and meningitis. Infectious Diseases of the Fetus and Newborn Infant, 6, 267-300.
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., & Hadler, J. L. (2011). Bacterial meningitis in the United States, 1998–2007. New England Journal of Medicine, 364(21), 2016-2025.
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004). Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases, 39(9), 1267-1284.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
